These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 30267663)

  • 1. Characteristics, properties, and potential applications of circulating cell-free dna in clinical diagnostics: a focus on transplantation.
    Sherwood K; Weimer ET
    J Immunol Methods; 2018 Dec; 463():27-38. PubMed ID: 30267663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-free DNA diagnostics in transplantation utilizing next generation sequencing.
    Jackson AM; Amato-Menker C; Bettinotti M
    Hum Immunol; 2021 Nov; 82(11):850-858. PubMed ID: 34600770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-derived Cell-free DNA in Solid-organ Transplant Diagnostics: Indications, Limitations, and Future Directions.
    Kataria A; Kumar D; Gupta G
    Transplantation; 2021 Jun; 105(6):1203-1211. PubMed ID: 33534526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-specific circulating cell free DNA as a noninvasive biomarker of graft injury in heart transplantation.
    Macher HC; García-Fernández N; Adsuar-Gómez A; Porras-López M; González-Calle A; Noval-Padillo J; Guerrero JM; Molinero P; Borrego-Domínguez JM; Herruzo-Avilés Á; Rubio A
    Clin Chim Acta; 2019 Aug; 495():590-597. PubMed ID: 31175849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a Clinical-Grade Assay to Measure Donor-Derived Cell-Free DNA in Solid Organ Transplant Recipients.
    Grskovic M; Hiller DJ; Eubank LA; Sninsky JJ; Christopherson C; Collins JP; Thompson K; Song M; Wang YS; Ross D; Nelles MJ; Yee JP; Wilber JC; Crespo-Leiro MG; Scott SL; Woodward RN
    J Mol Diagn; 2016 Nov; 18(6):890-902. PubMed ID: 27727019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myriad Applications of Circulating Cell-Free DNA in Precision Organ Transplant Monitoring.
    Burnham P; Khush K; De Vlaminck I
    Ann Am Thorac Soc; 2017 Sep; 14(Supplement_3):S237-S241. PubMed ID: 28945480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study.
    Schütz E; Fischer A; Beck J; Harden M; Koch M; Wuensch T; Stockmann M; Nashan B; Kollmar O; Matthaei J; Kanzow P; Walson PD; Brockmöller J; Oellerich M
    PLoS Med; 2017 Apr; 14(4):e1002286. PubMed ID: 28441386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of graft-derived cell-free DNA for solid organ transplantation.
    Zhang W; Liu B; Jia D; Wang R; Cao H; Wu H; Ye Z; Gao B
    Front Immunol; 2024; 15():1461480. PubMed ID: 39376561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating donor-derived cell-free DNA as a marker for rejection after lung transplantation.
    Li Y; Liang B
    Front Immunol; 2023; 14():1263389. PubMed ID: 37885888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-specific Cell-free DNA as a Biomarker in Solid Organ Transplantation. A Systematic Review.
    Knight SR; Thorne A; Lo Faro ML
    Transplantation; 2019 Feb; 103(2):273-283. PubMed ID: 30308576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid detection of donor cell free DNA in lung transplant recipients with rejections using donor-recipient HLA mismatch.
    Zou J; Duffy B; Slade M; Young AL; Steward N; Hachem R; Mohanakumar T
    Hum Immunol; 2017 Apr; 78(4):342-349. PubMed ID: 28267558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-Derived Cell-Free DNA Testing in Solid Organ Transplantation: A Value Proposition.
    Oellerich M; Christenson RH; Beck J; Schütz E; Sherwood K; Price CP; Keown PA; Walson PD
    J Appl Lab Med; 2020 Sep; 5(5):993-1004. PubMed ID: 32447378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of fragment size distribution of cell-free DNA: A potential non-invasive marker to monitor graft damage in living-related liver transplantation for inborn errors of metabolism.
    Ng HI; Zhu X; Xuan L; Long Y; Mao Y; Shi Y; Sun L; Liang B; Scaglia F; Choy KW; Zhu Z
    Mol Genet Metab; 2019 May; 127(1):45-50. PubMed ID: 31027872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary clinical experience applying donor-derived cell-free DNA to discern rejection in pediatric liver transplant recipients.
    Zhao D; Zhou T; Luo Y; Wu C; Xu D; Zhong C; Cong W; Liu Q; Zhang J; Xia Q
    Sci Rep; 2021 Jan; 11(1):1138. PubMed ID: 33441886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-free DNA as a solid-organ transplant biomarker: technologies and approaches.
    Edwards RL; Menteer J; Lestz RM; Baxter-Lowe LA
    Biomark Med; 2022 Apr; 16(5):401-415. PubMed ID: 35195028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free-Circulating Nucleic Acids as Biomarkers in Patients After Solid Organ Transplantation.
    Raszeja-Wyszomirska J; Macech M; Kolanowska M; Krawczyk M; Nazarewski S; Wójcicka A; Małyszko J
    Ann Transplant; 2023 Aug; 28():e939750. PubMed ID: 37580899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Noninvasive and Donor-independent Method Simultaneously Monitors Rejection and Infection in Patients With Organ Transplant.
    Zhou Y; Yang G; Liu H; Chen Y; Li X; Ge J; Wang X; Niu H; Dong W; Jiang T; Shi H; Peng L; Liu L
    Transplant Proc; 2019; 51(6):1699-1705. PubMed ID: 31399160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Size profile of cell-free DNA: A beacon guiding the practice and innovation of clinical testing.
    Shi J; Zhang R; Li J; Zhang R
    Theranostics; 2020; 10(11):4737-4748. PubMed ID: 32308746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fragmentation patterns of maternal plasma cell-free DNA and its applications in non-invasive prenatal testing.
    Pan M; Chen P; Lu J; Liu Z; Jia E; Ge Q
    Prenat Diagn; 2020 Jul; 40(8):911-917. PubMed ID: 32147843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.